How much is Innoventric worth in 2026?

Innoventric has a current valuation of N/A based on their Later Stage VC (Series B) round and secondary market data.

How much funding has Innoventric raised?

Innoventric has raised N/A in total funding across 1 funding rounds.

Innoventric

Therapeutic Devices

Innoventric valuation and funding history | Last updated: October 29, 2024 | 1 funding rounds

Current Valuation

N/A

As of October 29, 2024

Total Funding Raised

N/A

Across 1 round

Last Round

Later Stage VC (Series B)

$28.5M

Last Funding

Oct 2024

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
October 29, 2024	Later Stage VC (Series B)	$28.5M	N/A	-

Valuation Analysis

Current Valuation Metrics

Innoventric is currently valued at N/A as of October 29, 2024.

Track Innoventric Valuation Updates

Get notified when Innoventric raises new funding or valuation changes

Explore More Data

Detailed analysis for Innoventric

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Innoventric's valuation history, funding rounds, and growth metrics.

No credit card required

What is Innoventric Worth in 2026?

Innoventric is a leading private company in the Therapeutic Devices sector. Track Innoventric's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Innoventric Valuation is Determined

Private company valuations like Innoventric's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.